NCT01476267View on ClinicalTrials.gov

A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

dalcetrapib

Single oral radiolabeled dose

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01476267 - A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers | Biotech Hunter | Biotech Hunter